Reversible Host-Guest Crosslinks in Supramolecular Hydrogels for On-Demand Mechanical Stimulation of Human Mesenchymal Stem Cells.

Autor: Linke P; Physical Chemistry of Biosystems, Institute of Physical Chemistry, Heidelberg University, 69120, Heidelberg, Germany., Munding N; Physical Chemistry of Biosystems, Institute of Physical Chemistry, Heidelberg University, 69120, Heidelberg, Germany., Kimmle E; Physical Chemistry of Biosystems, Institute of Physical Chemistry, Heidelberg University, 69120, Heidelberg, Germany., Kaufmann S; Physical Chemistry of Biosystems, Institute of Physical Chemistry, Heidelberg University, 69120, Heidelberg, Germany., Hayashi K; Center for Integrative Medicine and Physics, Institute for Advanced Study, Kyoto University, Kyoto, 606-8501, Japan., Nakahata M; Department of Macromolecular Science, Graduate School of Science, Osaka University, Osaka, 560-0043, Japan., Takashima Y; Department of Macromolecular Science, Graduate School of Science, Osaka University, Osaka, 560-0043, Japan., Sano M; Institute of Natural Sciences, Shanghai Jiao Tong University, Shanghai, 200240, China., Bastmeyer M; Center for Integrative Medicine and Physics, Institute for Advanced Study, Kyoto University, Kyoto, 606-8501, Japan.; Cell and Neurobiology, Zoological Institute, Karlsruhe Institute of Technology, 76131, Karlsruhe, Germany.; Institute for Biological and Chemical Systems - Biological Information Processing (IBCS-BIP), Karlsruhe Institute of Technology, 76334, Eggenstein-Leopoldshafen, Germany., Holstein T; Center for Integrative Medicine and Physics, Institute for Advanced Study, Kyoto University, Kyoto, 606-8501, Japan.; Molecular Genetics and Evolution, Centre for Organismal Studies, Heidelberg University, 69221, Heidelberg, Germany., Dietrich S; Department of Internal Medicine V, Hematology, Oncology, Rheumatology, University Hospital Heidelberg, 69120, Heidelberg, Germany.; Department of Haematology, Oncology, and Clinical Immunology, Universitätsklinikum Düsseldorf, 40225, Düsseldorf, Germany., Müller-Tidow C; Department of Internal Medicine V, Hematology, Oncology, Rheumatology, University Hospital Heidelberg, 69120, Heidelberg, Germany., Harada A; The Institute of Scientific and Industrial Research, Osaka University, 8-1 Mihogaoka, Ibaraki, Osaka, 567-0047, Japan., Ho AD; Center for Integrative Medicine and Physics, Institute for Advanced Study, Kyoto University, Kyoto, 606-8501, Japan.; Department of Internal Medicine V, Hematology, Oncology, Rheumatology, University Hospital Heidelberg, 69120, Heidelberg, Germany.; Molecular Medicine Partnership Unit Heidelberg, EMBL and Heidelberg University, 69120, Heidelberg, Germany., Tanaka M; Physical Chemistry of Biosystems, Institute of Physical Chemistry, Heidelberg University, 69120, Heidelberg, Germany.; Center for Integrative Medicine and Physics, Institute for Advanced Study, Kyoto University, Kyoto, 606-8501, Japan.

Publikováno v: Advanced healthcare materials [Adv Healthc Mater] 2024 Apr; Vol. 13 (10), pp. e2302607. Date of Electronic Publication: 2023 Dec 25.

Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial.

Autor: Schubert ML; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Schmitt A; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Hückelhoven-Krauss A; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Neuber B; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Kunz A; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Waldhoff P; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Vonficht D; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Yousefian S; Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany., Jopp-Saile L; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Wang L; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Korell F; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Keib A; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Michels B; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Haas D; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Sauer T; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Derigs P; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Kulozik A; Department of Pediatric Hematology, Oncology and Immunology, University Hospital Heidelberg, Heidelberg, Germany., Kunz J; Department of Pediatric Hematology, Oncology and Immunology, University Hospital Heidelberg, Heidelberg, Germany., Pavel P; Institute for Clinical Transfusion Medicine and Cell Therapy (IKTZ), German Red Cross Blood Service Baden-Württemberg-Hessen, Heidelberg, Germany., Laier S; Institute for Clinical Transfusion Medicine and Cell Therapy (IKTZ), German Red Cross Blood Service Baden-Württemberg-Hessen, Heidelberg, Germany., Wuchter P; Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, of the Heidelberg University, German Red Cross Blood Service Baden-Württemberg - Hessen, Mannheim, Germany., Schmier J; GRN MVZ Sinsheim, Sinsheim, Germany., Bug G; Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt, Germany., Lang F; Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt, Germany., Gökbuget N; Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt, Germany., Casper J; Department of Hematology and Oncology, University Hospital Oldenburg, Oldenburg, Germany., Görner M; Department of Hematology and Oncology, Hospital Bielefeld, Bielefeld, Germany., Finke J; Department of Internal Medicine I, University Hospital Freiburg, Freiburg, Germany., Neubauer A; Department of Hematology, Oncology and Immunology, University Hospital Giessen und Marburg, Marburg, Germany., Ringhoffer M; Städtisches Klinikum Karlsruhe, Karlsruhe, Germany., Wolleschak D; Department of Hematology and Oncology, Center of Internal Medicine, Otto-von-Guericke University Medical Center, Magdeburg, Germany., Brüggemann M; Department of Internal Medicine II, University Hospital Kiel, Kiel, Germany., Haas S; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)/National Center for Tumor Diseases (NCT), Heidelberg, Germany., Ho AD; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)/National Center for Tumor Diseases (NCT), Heidelberg, Germany., Müller-Tidow C; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)/National Center for Tumor Diseases (NCT), Heidelberg, Germany., Dreger P; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)/National Center for Tumor Diseases (NCT), Heidelberg, Germany., Schmitt M; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. michael.schmitt@med.uni-heidelberg.de.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)/National Center for Tumor Diseases (NCT), Heidelberg, Germany. michael.schmitt@med.uni-heidelberg.de.

Publikováno v: Journal of hematology & oncology [J Hematol Oncol] 2023 Jul 22; Vol. 16 (1), pp. 79. Date of Electronic Publication: 2023 Jul 22.

Isolation of human mesenchymal stromal cells is more efficient by red blood cell lysis

Autor: Horn, P., Bork, S., Diehlmann, A., Walenda, T., Eckstein, V., Ho, Ad, Wagner, W.

Publikováno v: In Cytotherapy 2008 10(7):676-685

Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4.

Autor: Kayser S; Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany; NCT Trial Center, National Center of Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg. s.kayser@dkfz-heidelberg.de., Martínez-Cuadrón D; Hematology Department, Hospital Universitari i Politècnic, La Fe, València, Spain; CIBERONC, Instituto Carlos III, Madrid., Hanoun M; Department of Hematology and Stem Cell Transplantation, University Hospital Essen., Stölzel F; Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden., Gil C; Hospital General, Alicante., Reinhardt HC; Department of Hematology and Stem Cell Transplantation, University Hospital Essen., Aguiar E; Clinical Haematology Department, Centro Hospitalar São João, Oporto., Schäfer-Eckart K; Hospital Nord, Nurnberg., Burgues JMB; Hematology Department, Hospital San Pedro Acantara, Cáceres., Steffen B; Department of Internal Medicine II, University Hospital of Frankfurt Main., Bernal T; Hospital Central de Asturias, Oviedo., Krause SW; Department of Internal Medicine 5 - Hematology/Oncology, University Hospital of Erlangen., Riaza R; Hematology Department, Hospital Universitario Severo Ochoa, Madrid., Schliemann C; University Hospital Muenster, Muenster., Cervera J; Hematology Department, Hospital Universitari i Politècnic, La Fe, València, Spain; CIBERONC, Instituto Carlos III, Madrid., Kaufmann M; Robert Bosch Hospital Stuttgart, Stuttgart., Torres-Miñana L; Hematology Department, Hospital Universitari i Politècnic, La Fe, València, Spain; CIBERONC, Instituto Carlos III, Madrid., Hänel M; Klinikum Chemnitz, Chemnitz., Acuña-Cruz E; Hematology Department, Hospital Universitari i Politècnic, La Fe, València, Spain; CIBERONC, Instituto Carlos III, Madrid., Jost E; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, University Hospital RWTH Aachen, Aachen., Algarra JL; Hospital General de Albacete., Crysandt M; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, University Hospital RWTH Aachen, Aachen., Fransecky L; Department of Internal Medicine II, University Hospital of Kiel., Cornago-Navascues J; Fundación Jiménez Díaz, Madrid., Kraus S; Universitätsklinikum Würzburg, Würzburg., Martinez-Lopez J; Hospital 12 de Octubre, Complutense University, CNIO, Madrid., Einsele H; Universitätsklinikum Würzburg, Würzburg., Niemann D; Gemeinschaftsklinikum Mittelrhein gGmbH, Koblenz., Neubauer A; Philipps University Marburg, and University Hospital Giessen and Marburg, Marburg., Seggewiß-Bernhardt R; Medizinische Klinik V, Sozialstiftung Bamberg, Bamberg., Scholl S; Friedrich Schiller University, Jena., Klein SA; Medical Clinic III, University Medicine Mannheim, Mannheim., Schmid C; Department of Hematology and Oncology, Augsburg University Hospital, Augsburg., Schaich M; Rems-Murr-Klinikum Winnenden, Winnenden., Schmidt-Hieber M; Department of Hematology and Oncology, Carl-Thiem-Klinikum, Cottbus, Cottbus., Zukunft S; Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden., Ho AD; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg., Platzbecker U; Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig., Baldus CD; Department of Internal Medicine II, University Hospital of Kiel., Müller-Tidow C; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg., Thiede C; Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden., Bornhäuser M; Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden., Serve H; Department of Internal Medicine II, University Hospital of Frankfurt Main., Levis M; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland., Montesinos P; Hematology Department, Hospital Universitari i Politècnic, La Fe, València, Spain; CIBERONC, Instituto Carlos III, Madrid., Röllig C; Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden., Schlenk RF; NCT Trial Center, National Center of Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany; Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg.

Publikováno v: Haematologica [Haematologica] 2023 Jan 01; Vol. 108 (1), pp. 34-41. Date of Electronic Publication: 2023 Jan 01.

Cure of intravascular NK/T-cell lymphoma of the central nervous system by allogeneic hematopoietic cell transplantation.

Autor: Meissner J; Department of Medicine V, University of Heidelberg, Heidelberg, Germany. julia.meissner@med.uni-heidelberg.de., Schmitt M; Department of Medicine V, University of Heidelberg, Heidelberg, Germany., Andrulis M; Department of General Pathology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany.; Institute of Pathology, Klinikum Ludwigshafen, Ludwigshafen, Germany., Schweizer L; Department of Neuropathology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany.; Institute of Neuropathology, Charité, Berlin, Germany., Dietrich S; Department of Medicine V, University of Heidelberg, Heidelberg, Germany., Alber B; Department of Medicine V, University of Heidelberg, Heidelberg, Germany., Harting I; Department of Neuroradiology, University of Heidelberg, Heidelberg, Germany., Kurz FT; Department of Neuroradiology, University of Heidelberg, Heidelberg, Germany.; Department of Radiology, German Cancer Research Center, Heidelberg, Germany., Martens UM; Department of Hematology/Oncology, Clinics Heilbronn GmbH, Heilbronn, Germany., Ho AD; Department of Medicine V, University of Heidelberg, Heidelberg, Germany., Müller-Tidow C; Department of Medicine V, University of Heidelberg, Heidelberg, Germany., Dreger P; Department of Medicine V, University of Heidelberg, Heidelberg, Germany.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2022 Sep; Vol. 57 (9), pp. 1451-1454. Date of Electronic Publication: 2022 Jun 09.